Komori
Haba Laboratories (4925) · InitiativeAdvanced

Ensuring objectivity in director appointments and compensation decisions by the Nomination Committee and Compensation Committee

First written in FY2021. 3 of 5 entries say "Advanced", first in FY2023. Latest entry: FY2026.

5entries
6years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2021AdvancedFY2023 – FY2024OtherFY20252021: 120212022: 020222023: 120232024: 120242025: 120252026: 12026
Same theme, other companies
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 198 companies compared. The sentences above are computed from all 198.Comparing 200 of the theme's 749 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「Attendance at the Nomination Committee during the 43rd fiscal period, which held 5 meetings in total, was 100%.」

    The Nomination Committee and Compensation Committee each held 5 meetings, with a 100% attendance rate. The number of meetings increased from 4 each in the previous fiscal period.
  2. FY2025Decrease in the number of committee meetingsAnnual report

    「Attendance at the Nomination Committee during the 42nd fiscal period, which held 1 meeting in total, was 100%.」

    Both the Nomination Committee and Compensation Committee held 1 meeting during the 42nd fiscal period, with a 100% attendance rate. The number of meetings decreased from 4 each during the 41st fiscal period, as previously disclosed.
  3. FY2024AdvancedAnnual report

    「Attendance at the Nomination Committee during the 41st fiscal period, which held 4 meetings in total, was 100%.」

    The number of Nomination Committee meetings increased from 2 in the 40th fiscal period to 4 in the 41st fiscal period, with a 100% attendance rate. The Compensation Committee also held 4 meetings in total and had a 100% attendance rate.
  4. FY2023AdvancedAnnual report

    「Attendance at the Nomination Committee during the 40th fiscal period, which held 2 meetings in total, was 100%.」

    The Nomination Committee operated with 5 members, including outside directors who are Audit and Supervisory Committee members, held 2 meetings during the 40th fiscal period and had a 100% attendance rate. The disclosure also states that the Compensation Committee held 2 meetings in total and had a 100% attendance rate.
  5. FY2021First statedAnnual report

    「We have adopted the company-with-an-audit-and-supervisory-committee system. We have also established a Nomination Committee and a Compensation Committee as advisory committees to the Board of Directors. The Nomination Committee consists of 2 directors excluding directors who are Audit and Supervisory Committee members and 3 outside directors who are Audit and Supervisory Committee members. The Compensation Committee consists of 2 directors excluding directors who are Audit and Supervisory Committee members and 3 outside directors who are Audit and Supervisory Committee members.」

    This is the first thread describing the system under which the Nomination Committee and Compensation Committee, established as advisory committees to the Board of Directors and including outside directors, make recommendations concerning the appointment and dismissal of directors and director compensation.
Moved together

"Joint research and development of high-function products centered on the Life Science Research Institute" moved the same way as this thread, in the same document, in 3 of its 5 moves.

333222★123456
  1. ★This thread
  2. 1Joint research and development of high-function products centered on the Life Science Research Institute3×
  3. 2Sustainable growth and social contribution through ESG and SDGs initiatives3×
  4. 3Building the product and promotional foundation to increase the sales share of health foods3×
  5. 4Maximizing customer lifetime value starting with skincare products2×
  6. 5Synergies among mail-order, store-sales and distribution businesses and optimization of sales-promotion costs2×
  7. 6Implementation of a new core business system2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Haba Laboratories's next results are scheduled for 2026-11-13. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.